SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Sino Biopharmaceutical Agreement Covers Six Preclinical Asset Programs

The agreement covers six preclinical asset programs spanning ADCs and T-cell engagers.

Related stories